The latest health news includes FDA chief Richard Pazdur's concerns about new approval processes, a potential ALS treatment breakthrough, UK PM Boris Johnson's handling of COVID-19, Eli Lilly's market ...
The summary highlights significant developments in health, including FDA official Richard Pazdur's concerns over expedited ...
Scientists were pleased when they learned more about how the common cold gains a foothold in the body, identifying key ...
Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported.
Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported in the ...
The Hearty Soul on MSN
Doctors Warn of Rare Post-COVID Syndrome That Can Be Fatal
At first, it just seemed like a post-pandemic hangover: scattered patients drifting into Yorkshire clinics with damaged lungs ...
In "Planning Miracles," Jon Cohen chronicles the efforts of scientists and others to eradicate the threat of pandemics.
Inside a lab in the French city of Orleans, scientists are testing out the limits of molecules in our body called messenger ...
The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...
Now, scientists have published incredible findings from a Siberian mammoth they've named Yuka, revealing that they've found ...
People with ties to Brownstone Institute have significant authority over access to vaccines and scientific research.
Invivyd surged after Merck’s Cidara acquisition, but the read-through for IVVD is limited due to key differences. Learn why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results